From modules to medicine: How modular domains and their associated networks can enable personalized medicine - Wikidata - awgldk - TriplyDB

From modules to medicine: How modular domains and their associated networks can enable personalized medicine

From modules to medicine: How modular domains and their associated networks can enable personalized medicine

http://www.wikidata.org/entity/Q26830811

about

Human Prostate Cancer Hallmarks Map Identification of two regions in the p140Cap adaptor protein that retain the ability to suppress tumor cell properties.Computational methods and opportunities for phosphorylation network medicine Deciphering Phosphotyrosine-Dependent Signaling Networks in Cancer by SH2 Profiling Is phosphoproteomics ready for clinical research?Guided folding takes a start from the molecular imprinting of structured epitopes.Peptide receptor radionuclide therapy in a patient with disabling non-functioning pituitary adenoma.Functional characterization of phospholipase C-γ mutant protein causing both somatic ibrutinib resistance and a germline monogenic autoinflammatory disorder

P2860

Q26779590-5325DE32-FA89-4638-BE06-2B9454574CFE Q30009606-18A7D6F2-CD85-4A56-BF0A-6EFD2DE7A42E Q34742859-A1F89250-B692-46E5-ABD5-9D25240560A4 Q36443387-612DB29F-6EBA-4572-85DB-02DA3FF0AF8A Q36799469-200409A2-C719-46AF-8F6E-9386D9576EFA Q38831398-ADC047E8-4E4A-46F4-B2D4-2EF8E2C5582B Q50933634-A78F3E07-6977-4392-AAD4-50614616B25C Q57821054-6457A00F-88EE-4923-8A59-C34C033383DA

P2860

From modules to medicine: How modular domains and their associated networks can enable personalized medicine

http://www.wikidata.org/entity/Q26830811

description

2012 nî lūn-bûn

@nan

2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

From modules to medicine: How ...... n enable personalized medicine

@ast

From modules to medicine: How ...... n enable personalized medicine

@en

From modules to medicine: How ...... n enable personalized medicine

@nl

type

label

From modules to medicine: How ...... n enable personalized medicine

@ast

From modules to medicine: How ...... n enable personalized medicine

@en

From modules to medicine: How ...... n enable personalized medicine

@nl

prefLabel

From modules to medicine: How ...... n enable personalized medicine

@ast

From modules to medicine: How ...... n enable personalized medicine

@en

From modules to medicine: How ...... n enable personalized medicine

@nl

P1433

Q26830811-8EF7B159-899B-4F0F-8E82-82D91B016B02

P1476

Q26830811-0392555A-BC85-4144-ABD0-1734DB783203

P2093

Q26830811-C49D0834-7C69-43FD-8EA1-D3ED64F84F03

P2860

Q26830811-0B8B8BCC-CE98-46A6-9501-147820066D56

Q26830811-0E4E3F0F-A5AA-425E-B79C-D6206096E870

Q26830811-0F0E6F8C-BC7A-4179-ACA1-6B0DA069AF48

Q26830811-105A3508-4D81-46CA-8726-24C028B1868F

Q26830811-11A17E9E-43B6-478A-917A-2382FE8264E3

Q26830811-13C190A2-CBEF-41EC-9821-8593A5952E7A

Q26830811-13E33B1E-99C1-42C4-A108-1EB3DA29CCA7

Q26830811-14861F4B-3908-4392-AE54-4F431E40BBFE

Q26830811-29620245-B93B-41CA-B523-212C48FE3B04

Q26830811-2B90091C-9D03-4CA9-87D0-18D38A13ECE6

P304

Q26830811-DEC9DC46-D01C-4920-9E4F-C54747B5C04C

P31

Q26830811-CFF7A834-AAD4-489D-8601-38E23D454E6D

P3181

Q26830811-1C0FA838-7A8F-40E3-AB65-1E874D235285

P356

Q26830811-BA0812B0-A6C2-4BBD-86B1-EF1CBBBE7C2B

P407

Q26830811-C5E5079F-9C4F-40A3-9121-0F93BB9AC756

P433

Q26830811-9E3F232F-BAC7-425A-803F-E197B293CBB2

P478

Q26830811-6DB3847B-752D-4E56-BF28-7E1E2B845A61

P577

Q26830811-5165DE81-F466-4AFA-8E44-ED58F6C75AFF

P5875

Q26830811-3CF2FAA5-878D-4CE6-AFAB-F351B55934ED

P698

Q26830811-0B8CB419-DBBC-44C9-9D5E-AF7B30854378

P932

Q26830811-E7152EA7-6403-4DC7-A99A-5ACA891565F2

P3181

P356

J.FEBSLET.2012.04.036

P1433

P1476

From modules to medicine: How ...... n enable personalized medicine

@en

P2093

Eric B. Haura

http://www.w3.org/2001/XMLSchema#string

P2860

Characterizing proteins and their interactions in cells and tissues using the in situ proximity ligation assay

An integrated workflow for charting the human interaction proteome: insights into the PP2A system

Functional interaction of DYX1C1 with estrogen receptors suggests involvement of hormonal pathways in dyslexia

A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

Characterizing the cancer genome in lung adenocarcinoma.

The human disease network

Characterizing tyrosine phosphorylation signaling in lung cancer using SH2 profiling

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors

P304

2580-5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4210608

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.FEBSLET.2012.04.036

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

586

http://www.w3.org/2001/XMLSchema#string

P577

2012-08-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224939067

http://www.w3.org/2001/XMLSchema#string

P698

22575759

http://www.w3.org/2001/XMLSchema#string

P932

4084654

http://www.w3.org/2001/XMLSchema#string